Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing only ethinylestradiol and norgestrel in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol and segesterone only product in vaginal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Cyproterone and ethinylestradiol only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing only drospirenone and ethinylestradiol and levomefolic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing only ethinylestradiol and ferrous fumarate and norethisterone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Drospirenone and ethinylestradiol and levomefolic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol- and ferrous fumarate- and norethisterone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |
Ethinylestradiol betadex clathrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
|
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ethinylestradiol |
Inferred relationship |
Some |
1 |